NCT04851912

Speech-based Digital Biomarker for Psychiatric Disease

Preclinical Development of a Speech-based Digital Biomarker for Psychiatric Disease

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Winterlight Labs · Industry
• Sex: All
• Age: 18 Years – 95 Years
• Healthy volunteers: Accepted

Summary

The general objectives of this study are to build a proof-of-concept, speech-based, digital biomarker for identifying the presence and tracking the severity of psychiatric disease.

Detailed description

The purpose of this study is to gather longitudinal data to examine how speech features and symptoms change over different intervals of time and the reliability of repeated, high frequency test administration. Participants will complete a variety of speech and language tasks using the Winterlight Assessment (iOS app) everyday for 30 days. The following is the list of assessments that participants will complete; 1) Daily assessment of mood, 2) Winterlight assessment which contains a series of verbal response tasks where participants are recorded through a tablet app, and 3) Clinical assessments.

Conditions

• Speech
• Psychiatric Disorder
• Language

Interventions

Type	Name	Description
OTHER	Winterlight Apps	Longitudinal speech recordings

Timeline

• Start date: 2021-04-27
• Primary completion: 2023-12-01
• Completion: 2023-12-01
• First posted: 2021-04-21
• Last updated: 2022-09-27

Locations

1 site across 1 country: Canada